Tag: Myeloid
Fortis and Agilus expand rapid genomic testing capabilities with launch of...
The Genexus platform enables Next-Generation Sequencing (NGS) with an unparalleled turnaround time - delivering crucial results such as Liquid Biopsy in 24 hours, Myeloid NGS in 72 hours, and MRD testing within 5 days